Drug intelligence / Profile preview

SULGEN

Development stage
Unknown
Lead developer
Roxall Medizin
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

SULGEN is a brand name for a product line of sublingual immunotherapy (SLIT) treatments developed and manufactured by ROXALL Medizin GmbH. [16, 18, 19] The products consist of native allergen extracts, derived from sources like pollen, mites, molds, or animal epithelia, formulated in a glycerin solution and administered as a sublingual spray. [20, 22] SULGEN is a form of allergen-specific immunotherapy designed to treat Type I allergic diseases, including allergic rhinitis and rhinoconjunctivitis. The therapy works by inducing immunological tolerance to the specific allergen, which can reduce or eliminate the allergic symptoms over time. [29] The product line includes various formulations targeting different allergens, with some in Phase 2/3 clinical development for indications such as birch and grass pollen allergies.

Brand names
SULGEN
Other names
SULGEN Spray Betula verrucosaSULGEN Spray Phleum pratenseSULGEN Spray Dermatophagoides pteronyssinusSULGEN Spray PollenSULGEN Spray MilbenSULGEN Spray SchimmelpilzeSULGEN Spray Tier Epithelien

Beyond the preview

Go deeper on SULGEN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SULGEN.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call